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Conclusions: Complex studies on propemes of C.d. strains, 
circulating in Belarus, could be applied for the determination of 
pathogen origin, ways of its transmission, whch are an object of 
special importance for diphtheria surveillance. 
I P593 I Detection and Differentiation of Leptospira sp. 
by PCR Method 
M. Witkowska I ,  A. Samet I ,  T. Kocik ', A. Burluewicz ', J. Kur 3 .  
'Dept. of Clinical Bacteriolofl, State Clinical Hospital W 1, Poland, 
Eterinary Hygiene Research Institute, Poland, 'Dept. of Microbiology, 
Echnical University of Gdansk, Poland 
Objectives: Detection of Leptospira sp. in clinical specimens. Daer- 
entiation of Leptospira serovars with (1) junction of two techniques: 
polymerase cham reaction (PCR) and restriction fkgment length 
polymorphm (RFLP), and (2) fingerprinting polymerase chain re- 
action (FP-PCR). 
Methods: Twenty seven cultures' of Lepfospira serovars and Lep- 
tospira icterohaemodagiae serially diluted strains (in blood, sperm and 
urine) were tested by PCR with Leptospira genus-specific primers. 
Experimentally infected blood samples were examined by the Same 
test. Nineteen Leptospira serovars were analyed by FP-PCR with L1 
and G1 primers. The 16s rRNA of Leptospira se rom genes were 
amplified with PCR and analysed by RFLP with AfuI enzyme. The 
DNA was extracted by kits made by A&A Biotecbnology, Poland. 
Results: The Leptospira DNA was detected in urine, sperm and 
blood. The PCR test enables detection of 10 Leptospira cells in PCR 
probe and was genus-spec& for all tested samples. Total time of 
the test was less than 6 h. Leptospires can be detected in blood on 
second day of the dection. Both tests PCR-RFLP and FP-PCR 
gave partidly differentiation of Lqfospira semvars. 
Conclusion: Test based on PCR technique is useful for quickly, 
sensitive and specific detection of leptospires in blood, sperm, urine, 
and give very early diagnosis of leptospirosis. Both diflerentiating 
tests may be used in epidemiological studies as alternative, additional 
method. 
I P594 I Early Serodiagnosis of Serious Forms of 
Leptospirosis by ISM-ELSA 
J.L. L6pez-Hontangas, M. Salavert, F. Ponz, I. Ceniceros I ,  
I. Gutierrez, M. Gobernado. Deparf?nent ofMicrobiology and Intensive 
Care Unit, Hospital L4 FE, VaJencia, Spain 
Objectives: To study the epidemiological and climcal findings of 
leptospirosis in our geographical area, and to evaluate the utility 
IgM-ELSA test to detect leptospire-specific immunoglobulin M for 
early serodragnosis of severe forms. 
Patients and Methods: Fifteen patients with clinical diagnosis of 
leptospirosis were evaluated. A technique of indirect hemagglutina- 
tion (IH) (HilLrest B i d )  as test for screening was used. A title > 1 :50 
was considered negative. To detect the IgM anti-leptospira specific 
of gender an ELISA (PanBio) was employed. 
Results: From January 1993 to December 1996 the diagnosis of 
leptospirosis was made in 15 patients out of 86 patients with initial 
suspicion. Seroconvenion or initial positive title of IH was detected 
in 8 patients. In 11 patients with initial negative or doubtfid titles of 
IH, IgM ELISA was positive in 9 of them. Of 9 patients with initial 
IH negative or doubtll and IgM-positive, 5 of they had serious 
dlsease. From all patients eight sdered a serious leptospirosis and 
three died. Four patients needed admission in a intensive care unit. 
During the clinical course renal failure was observed in 7 cases, 
rabdomiolyss in 6, tbrombopenia in 6, meningoencefalitis in 3 and 
shock with multiple organs failure in other 3. 
Conclusions: Leptospirosis had a severe presentation in approx- 
imately 50% of the cases and a mortality rate of 20% of the global 
series. A high incidence of severe renal, pulmonary affectation, and 
rabdomiolysis was observed. The determination of IgM anti-lepto- 
spira by IgM-ELSA improves the efficiency of the usual serodganosis 
by IH, mady  in the most serious forms ofleptospirosis. 
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1 P595 I Simultaneous Presence of Two Botrelia 
burgdorfrrisensu lato Species in lxodes ricinus 
Ticks 
J. Jenek. Knml Marcinkowski University ofMedical Sciencer in Poznari, 
Hematophagous arthropods, lvodes ricinus ticks are transmitters of 
agent of Lyme disease Bonefia bufgdofm' to men and animals. Re- 
cently it has been demonstrated that DNA fiom more than one of 
the three Borrelia burgdorferi sensu lato species was present I. ricinus 
nymphs @chon et al., Emerging Infect. Dis., 1995; 1 (3): 89-90). 
We analyzed 15 h m  73 PCR positive for Bomlia DNA ticks genek 
and Glazaczow, Przeg. Epid., 1996; 50: 383-386) for simultaneous 
presence of more than one genospecies in unfed adult ticks by using 
PCR amplification of flagelin gene fiagment and hybridization with 
genospecies-specific probe. 
Thirteen ticks were dected by a smgle species of Bomlia (eigth 
by B. garinii and five by B. afzelii; Boneh burgdofm' sensu sfricfo was 
not found), and two were infected by both B. garinii and B. afzzdii. 
These p r e h a r y  data suggest that the simultaneous presence of 
more than one genospecies in arthropod vector may be not excep- 
tional. 
Poland 
lp5961 Botrelia burgdorfrm'sensu lato DNA in Setum of 
Patients with Early Lyme Disease 
J. Jenek, A. Szkaradkiewicz, T. Tdecka. Karol Marcidmwski 
University ofMedical Sciences in PoznaA, Poland 
The studies aimed at evaluating dugnostic capacity of PCR tech- 
nique and of serological techniques in erythema chronicum migrans 
(ECM) dlagnosis. 
Reaospective studies on Borrelia burgdot$+ (B.b.) DNA presence in 
serum of patients with early bomkosis were conducted using PCR 
and hybridzation with specific probe. F~fiy four sera were tested 
earlier for presence of anti-B.b antibodies (Enzygnost Borreliosis, 
Behring). High titre of specific anti-B.b. antibodies were found in 9 
sera (IgG antibodies in 3 sera, IgM antiborhes in 3 sera and in 3 sera 
both types of antibodies). In 7 cases specific activity of serum IgM 
was at the trace level. Presence of 8.6. DNA was noted in 16 sera of 
which 5 only contained specific anti-B.b. antibodies. 
The obtained results indicate that ECM diagnostics based on im- 
munoserological techniques is insuflicient and in clinically suspected 
cases should be supplemented by PCR studies. 
[ P597 I Lyme Disease as an Epidemiological Problem in 
Z. Anusz, A. Horban, E. Marcinkowska, M. Poniewierski. I.fectious 
Diseaies Hospital, Warsaw, Poland 
The first serological study in group of a hgh  risk was carried out 
in Poland in 1991 (Anusz et al.). In 61 out of 417 persons (14.6%) 
antibodies against Bomlia bufgdofm' were found. 
Poland 
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Since 1996 borreliosis must be obligatory registered and reported 
to the Department of Public Health. In the first quarter 20 cases 
were reported, in the second 41 cases, in the third quarter 308 
cases. One hundred seventeen patients (31.7%) were hospitalized. 
The biggest group of patients was reported in the forest areas: Bia- 
lystok 53 (14.4%), Olsztyn 30 (8.1%), Bydgoszcz 30 (8.1%), Suwalki 
28 (7.6%). 
We presume that &IS number is underestimated. In 1995-1996 
years in our hospital only we observed 188 patients with newly 
recognized Lyme disease. One hundred seventy six patients were 
addmmed with erythema migrans, eleven with symptoms of phase 
11, one in phase 111. 
F/ Lyme Disease among the lnhabitants of the 
S .  Pancewicz, A. Januszkiewicz, E. Siwak, 
T. Hermanowska-Szpakowicz, J. Zajkowska, W. Krupa, 
M. Pryszmont. Department of Neuroinjction in Medical Academy in 
Bialystok, Poland 
The purpose of this study was to estimate fkquency of Borre- 
lia burgdorferi antibodies detection among 1765 inhabitants in the 
north-eastern part of Poland. 1101 of whole number came fium 
a hgh risk group exposed to direct contact with the tick Ixodes 
ricinus (persons employed in the woods and lnhabitants of +es 
situated close to the woods). Active Lyme disease was diagnosed in 
191 persons (45.0%). The rest 227 were antibody carriers (54.4%). 
Regarding the whole number of 1765 persons examined it equals 
adequately 10.8% of persons with active Lyme disease and 12.8% of 
antibody camers. 
Among 191 persons with systemic changes the following disor- 
ders were identified Erythema migrans (6.11%), Lyme arthritis in 
87 persons (14.92%), Neuroborreliosis (1.92%), Lyme carditis in 11 
(0.62%) keratitis in 1 (0.05%) and iritis in 1 (0.05%). 
North-Eastem Part of Poland 
I P599 I Lyme Disease - One Year Follow-Up of 98 Pts 
E. Marcinkomka, A. Horban, Z. Anusz, H. Zarnowska. Hospitalfor 
Infectious Diseases, Warsay Poland 
We observed 98 persons (74 women, 23 men, range 15-80 y, mean 
range 47y). Ninety seven pts had erythema migrans. In 1 case fiat 
clinical symptoms suggested neuroboreliosis. Only 19 pts had other 
symptoms. Phase I1 of disease was observed in 9 cases: arthritis (7), 
neuroboreliosis (l), erythemas multiplices (l), phase 111 in 1 case. 
Antibodes were detected with ELISA (DAKO LYME) after 3, 6, 9 
months of onset. Seventy seven patients were treated with Amoxicillin 
(1.54 g/d) for 21 days, 14 consecutive with Doxycycline (200 mg/d) 
for 21 days, 2 pts were treated by various regimens. Five pa  were 
not treated in phase I. In phase I1 and 111 Doxycycline (200 mg/d) or 
Cefhinxone (2g/d) had been administered. Four pts needed retheram. 
None of seronegative pts had phase I1 and I11 symptoms, 9.2% of 
seropositive pts had phase I1 and 1% had phase 111. Among pts treated 
with Amoxicillin antibodies were found in 58% and phase I1 of dsease 
was observed in 5.1%. Among pts treated with Doxycycline there were 
found in 50% and 7.1% respectively. M e r  12 months of onset no 
one had any signs or symptoms of Lyme &ease. 
(1) Data suggest that an early antibiotic treatment prevents phase I1 
(2) Both Amoxicillin and Doxycycline therapy seem to be good treat- 
Conclusions: 
of Lyme disease. 
ment in erythema migrans. 
1 P600 I Immune Complexes in Course of Lyme 
Bomliosis 
S. Tylewska-Wierzbanowska, T. Chmielewski. Department of 
hcteriolon, National Institute of Hygiene, Warsaw, Poland 
Lyme borreliosis is a multi-step disorder with variety of symptoms 
and pathologic processes. It has been suggested that in course of 
chronic progressive Lyme borreliosis observed manifestations are a 
result of development of immunologically based disease and forma- 
tion of immune complexes. 
Patients with c h c a l  symptoms of Lyme borreliosis at dif€erent 
stages were tested. Level of serum antibodies specific to B. burgdofri 
was estunated with recombinant Igh4 and IgG ELISA (Biomedica, 
Austria) and blood samples were cultured to isolate spirochetes. In 
cases of negative results of serological testing, patients' sera were 
pre-treated to precipitate and dissociate immune complexes. After 
that treatment level of antibodies specific to B. burgdofen was evalu- 
ated. 
It has been found that in seronegative Lyme borreliosis patients 
antibodies to B. burgdofm' form immune complexes. The Lnfection 
has been confirmed by isolation of spirochetes h m  blood. 
The detection of immune complexes formed by B. burgdofm' an- 
tibodies is a valuable test which can improve diagnosis of the disease 
and may be helpful in establishmg more complex treatment of the 
infection as well as it's sequelae. 
I P601 I Evaluation of the Specific Cellular Immune 
Response to Bomlia burgdotii?ti Soluble 
Antigens in Lyme Disease 
T. Malovrh', V. Kotnik ', A. Paternoster', E. Ruzic-Sabljic 
J. Cimperman ', E Sterle', A. K0tnik3. 'Institute ofMinobiology and 
Immunolon, Medical Faculty Ljubljana, Slovenia, 'Department of 
Infectious Diseases, University Medical Center Ljubljana, Slovenia, 
'Department .f Viroloa, Institute $Public Health ofthe Republic of 
Slovenia, Slovenia 
Objectives: Detection of the infection with Borrelia burgdofri is 
still controversial. Clinical signs and the results of laboratory testings 
are not contributing enough to the diagnosis of the disease. In our 
laboratory we are performing for years specific lymphocjte blast 
transformation test (TTL) with Borrelia burgdo@i soluble antigens. 
The aim of the study was how this test contribute to the diagnosis 
of Lyme disease. 
Methods: We performed historical cohort study reviewing lab- 
oratory data (TTL) of 800 patients with clinical signs relevant for 
Lyme disease. 213 of them were were selected according to the clin- 
ical signs in five groups. The first group was composed of patients 
with verlhed erythema migrans, the second group of patients with 
cardial and neurological signs, the third group of patients with acro- 
dermatitis chmnica atmphicans, arthritis and encephalomyelitis, in 
the fourth group were patients with non-specific, but with lyme dis- 
ease often connected symptoms, and in the fifth group patients with 
signs belonging to more then one of the first four groups. 
Results: 45.8% of the patients in the first group had positive 
cellular immune response, 57.1% in the second group, 11.1% in the 
third group, and 22.1% in the fourth group. Patients fium the fifth 
group had positive cellular immune response in 37.2%. 
Conclusion: Available laboratory tests for cellular and humoral 
immunity can not give the straight forward answer characteristic for 
the efficient immune response to Bomlia burgdofm' mfection. 
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[ E l  Characterization of Slovenian Lyme borreliosis 
spirochetes 
E. Rukit-Sabljit I ,  E Strle’, J. Cimperman’, S. Lotrit’, 
V Maraspin2. ‘Inst. ofMicrobiology, Ljubljana, Slovenia, ’Dp t .  
Infectious Dis., Medical Faculty Ljubljana, Slovenia 
Objectives: LB is the most prevalent tick-borne infection in Slove- 
nia. The signs and symptoms of LB vary, the most common dini- 
cal manifestation is skin rash, EM. Disseminated infection includes 
severe neurologic, cadac, skin, and arthritic manifestations. Pheno- 
typic characteristic and genetic Merendation of LB spirochete has 
been performed. In the present study, we analyzed-24 B. burgdorjm’ 
sensu lato s t r a i n s  isolated from the skin of Slovenian patients. 
Methods: Skin biopsies were inoculated &to the MKP medium, 
incubated at 33°C and weekly examined for spirochetes by dark-field 
microscopy. Protein profdes were determined by PAGE after b o h g  
spirochetes with 2.5% SDS. Species identdication were determined 
by PFGE using Mlul restriction. 
Results: Mlul digestion profeiles showed that 20 (83.4%) isolates 
belong to B. afielii and 4 (16.6%) to B. garinii, none B. burgdorjeri 
sensu strict0 strain has been evidenced. All B. garinii strains have 
been isolated b m  the patients with EM, while B. afielii strians 
were cultured: 15 b m  EM, 3 f b m  ACA and two fbm the s k i n  
of previous EM. Borreliae showed quantitative differences in the 
amount of expressed proteins, OspC was the most frequently hghly 
expressed. OspA and OspB proteins have been expressed by 19 (95%) 
B. a f i l i i  and two (50%) B. garinii strains, OspC by 10 (50%) B. ofzelii 
and all B. garinii strians. 
Conclusions: In Slovenia, skin disorders are the most fiequent 
chca l  madestations of LB and B. afielii is dominant strain from 
the LB spirochetes complex. 
lP603( Comparison of Home-Made IFA with 
Commercial ELISA Assays for Diagnosing Lyme 
Disease 
A.M. Zore’ , E. RuZit-Sabljit 
S. Lowit’, V Maraspin’. ‘Inst. ofMinobiology, Medial  Faculty in 
Ljubljana, Slovenia, ’Dept .  for Infectious diseases, Medicnl Faculty in 
Ljubljana, Slovenia 
Objectives: Cornparison of sensitivity and specificity of two com- 
mercially available ELISA tests and home-made IFA test for detecting 
IgG and IgM against Borrelia burgdo@ (BB). 
Methods: Serum samples of 198 patients suspected to have Lyme 
disease (LD) and of 214 healthy persons (HP) were tested with Lyme 
Behring ELISA (Behring, Mannheim, Germany), Dako Lyme Bor- 
reliosis ELISA (Dako, Gloshup, Denmark) and home-made IFA tests 
for IgG and IgM against BB. ELISA assays were performed according 
to the manufactures’ instructions. For IFA antigen w a s  used st ra in  of 
B. aftelii, the most fiequent Slovenian isolate. 
Results: The sera of group of healthy persons were IgM 97.2% 
negative by IFA, 82.7% negative by Behring ELISA and 90.6% by 
Dako ELISA. IgG were 87% negative by IFA, 56.3% negative by 
Behring ELISA and 84.9% negative by Dako ELISA. The sera of pa- 
tients with erythema migrans were IgM 80% negative by IFA, 37.5% 
negative by Behring ELISA and 52.5% by Dako ELISA. IgG were in 
this group 80% negative by IFA, 57.5% negative by Behring ELISA 
and 65% by Dako ELISA The sera of patients with other manifes- 
tations of Lyme disease were IgM negative in 90% by IFA, 55.7% by 
Behring ELISA and 54.4% by Dako ELISA. IgG were 64.5% negative 
by IFA, 38.6% by Behring ELSA and 50% by Dako ELISA. 
Conclusions: The best sensitivity and specificity have been 
achieved by home-made IFA. The commercial ELISA tests should 
be used for serological screening because of its increased sensitivity. 
E Sale’, J. Cimperman2, 
Erythema Migrans in the lmmunocompromised 
Host 
V. Maraspin, E Strle, S. Lotrit-Furlan, J. Cimperman, 
E. Rukit-Sabljit. University Medical Centre, Ljubljana, Slovenia 
Objectives: To assess the course and the outcome of antibiotically 
treated immunocompromised patients (ICP) with erythema migrans 
(EM). 
Methods: In the period b m  1991 to 1995,49 adult patients with 
typical erythema migrans and previously identified immunocompro- 
mised condition were investigated and followed-up for one year at 
the Lyme borreliosis Outpatients’ Clinic, University Department of 
Infectious Diseases, Ljubljana, Slovenia. 
Results: There were 26 females and 23 males, aged from 17 to 77 
years (medan 58 years), suffering from dfferent causes of immun- 
odeficiency. The results were compared with 49 previously healthy 
age, sex and antibiotic therapy matched persons with an EM. Clin- 
ical characteristics of Lyme borreliosis (LB) before treatment were 
similar in both groups. The majority of patients were treated with 
an oral antibiotic, only three (6.1%) ICP and two (4.1%) controls 
received an i.v. antibiotic because of signs of early dissemination of 
LB. The median duration of EM after the institution of therapy was 
10 days (2-90) in the ICP group and 14 d a y s  (2-90) in the control 
group (nonsigdcant difference). 
Among the ICP five (10.2%) patients developed minor and three 
(6.1%) major manifestations of LB, while in the control group in 
three patients (6.1%) minor manifestations were observed and none 
developed major d e s t a t i o n s ;  all required a retreatment with an 
i.v. antibiotic. 
Conclusions: The course and the outcome of early LB in im- 
munocompromised patients seem to be sirmlar as in normal popula- 
tion. 
[p605] Cefuroxime Axetil (CEF), Doxycycline (DOX) and 
Amoxicillin (AM) for Treatment of Solitary 
Erythema Migrans (EM) 
E Strle, V. Maraspin, S. Lotrit-Furlan, E. Rukit-Sabljit, T. Jurca, 
J. Cimperman. University Medical Centre, Ljubljana, Slovenia 
Objectives: To compare effectiveness and adverse effects of cefurox- 
ime axed, doxycydine and amoxicillin for weatment of EM. 
Methods: The study was prospective and began in 1994. For 
the presentation in this report 210 adult patients with previously 
untreated typical solitary EM were selected, i.e., the first 70 patients 
treated with CEF (500 mg bid for 15 d a y s ) ,  DOX (100 mg bid for 
15 days), or AM (1000 mg tid for 5 days, followed by 500 mg tid for 
additional 10 days) who were followed-up for one year. 
Results: The median duration of s h  lesions after the institution 
of treatment was 10 (3-21) days in the CEF group, 11 (3-30) days 
in the DOX group, and 9 (2-28) days in patients treated with AM 
(nonsigdcant diflerences). During the follow up of 12 months 2 
patients (1 in DOX and 1 in AM group) developed major later man- 
ifestations of Lyme borrehosis, and in 42 (20%) patients minor man- 
ifestations appeared in 13 (18.6%) treated with CEF, in 17 (24.3%) 
receiving DOX, and in 12 (17.1%) given AM. Bomlia burgdorjm’ 
sensu lato w a s  isolated from the periphery of EM lesions in 23/62, 
30/65, and 33/68 patients before treatment with CEF, DOX, and 
AM, respectively. In 1/30 culture positive patient in DOX group, in 
1/23 in CEF group and in 0/33 in AM group B. burgdorfoi sensu 
lato was isolated again b m  normal appearing skin at the site of pre- 
vious EM 2 months after institution of antibiotic therapy. Seven, 11, 
and 6 patients receiving CEF, D O X  and AM, respectively, reported 
mild to moderate gastrointestinal discomfort. In addition, 8 patients 
ti-eated with DOX developed photosensitivity. 
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Conclusions: CEF, D O X  and AM have similar effectiveness, but 
adverse effects are sigtllficantly more fkquent in patients treated with 
DOX. 
OspC wxs identified more often than OspA. In the late stage anti- 
body response against OspA was more fiequent than against OspC. 
Among cross-reacted sera the greatest part of B. burgdoferi antigens 
were discerned h m  syphilitic sera. 
I P606 I Treatment Failure in Erythema Migrans 
B. Sibanc, G. LegniLar, S. Cvitan, J. Blatnik. Department oflnfectious 
Diseases, General Hospital, Cefie, Slovenia 
Objectives: We talk about erythema migrans (EM) treatment fail- 
ure whenever we see: 1. EM persistence 2. EM reoccurrence, 3. 
persistence or development of extracutaneus sequelae (major signs 
and minor symptoms), 4. persistent increase of antibody titers, 5. 
persistence of Borrelia burgdoferi. 
Methods: EM has been treated in General hospital Celje - Infec- 
tious department since 1981. In years 1994-1996 544 lyme patients 
were treated. 323 of them had typical EM and consequent progress 
in lyme cksease, whlch inckcate the need for hospital treatment with 
ceftriakson (Lendacin). Among them, we found 51 properly treated 
EM patients, who show progress of illness. 28 patients were treated 
with azithromycin, 7 with doksicyclme, 6 with penicilin V, 4 with 
consequent administration of two proper antibiotics (ATB), 6 with 
other ATB-s. 
Results: Only 10 patients had minor signs at the time ofEM per- 
sistence and 13 were seronegative at the end of our study. 6 patients 
(5 children) developed disseminated EM, 11 arthritis, 3 meningoen- 
cephaiitis, 1 pericarditis, 1 facial palsy, 29 minor symptoms which 
persisted more than 3 months or even upgraded. 
Conclusions: AU patients were treated with cefniakson 2 g/d i.v. 
2-4 weeks. After that time, 25 patients were cured, 20 patients im- 
proved partially but in 6 patients there were no signs of improvement 
at all. 
Disappearance of EM after treatment does not necessarily mean 
cure of Lyme borreliosis, even when we use "proper ATB-s" long 
enough 
I P607 I Electrophoretic and Immunologic 
Characterization of6orrelia burgdohn Isolated 
in Bulgaria 
I. Christova, M. Polianova, L. Froloshka. National Center oflnfecfious 
Diseases, Sofa, Bulgaria 
Objectives: To basically characterize Bulgarian B. burgdoferi isolates 
as well as humoral immune response in Lyme dIsease patients against 
them. 
Methods: Thirteen Bulgarian B. burgdorferi isolates /11 h m  I .  
rioinus ticks and 2 h m  skin biopsies from Erythema migrans pa- 
tients/ were analyzed by sodium dodecyl sulfate - polyacrylamide 
gel electrophoresis /SDS-PAGE/ and by immunoblotting with sera 
h m  patients with Lyme disease. Cross-reacted sera from patients 
with syphilis, leptospimsis and lupus erythematodes served to dis- 
criminate between specific and nonspecific bands in immunoblots. 
Results: Regarding Merent species-specific B. burgdoferi 
OspA/OspB electrophoretic migration, basic identification of the 
isolates was made. Early humoral immune response in Lyme disease 
patients was found to be directed mainly against OspC and 41 kDa 
antigen, and very rarely against OspA. In the late stage of the disease 
antibohes were proven especially against 41 kDa, 66 kDa, OspA and 
only in single cases against OspC. 
Conclusions: SDS-PAGE characterization of Bulgarian B. 
burgdorjki isolates revealed considerable predomination of B. garinii 
both among tick and skm isolates. By sera h m  patients with Lyme 
disease the following major antigens in the isolates were proven - 
66 kDa, 41 kDa, OspA, OspC. In the early stage of the disease 
Marseilles Fever and Lyme Borreliosis 
L. Angelov, T. Rakadjieva, R. Komitova, M. Pishmisheva, 
I. Hristova. Higher Medical Institute, Plovdiv, Bulgaria 
Some of our recent epidemiological studies have shown that human 
cases of Lyme borreliosis (LB) are reported h m  areas where the 
environmental conditions are not optimal for the life cycle of the tick 
species I. ricinus. These areas are recognised as foci of Marsedles fever. 
It is known that the symptoms of LB vary h m  patient to patient 
and often mimic other conditions. For this reason it is &cult for 
the clinician to distinguish between the two infectious disease. 
Objective of the study: To analyze the clinical manifestations of 
LB and Marseilles fever in a random sample of patients. An effort is 
made to establish the best therapeutic approach to these patients. 
Methods: The techniques of indirect immunofluorescence and 
ELISA. 
Results: 22 patients living in an area recognised as endemic 
for Marseilles fever were studied. Some of them developed clin- 
ical symptoms of LB and were serologically positive for infection 
with B. burgdoferi. Some domestic animals also tested positive for LB 
and Marseilles fever. 
Conclusions: The epidemiological evidence presented in this 
study gives us the grounds to consider that coinfections with B. 
burgdo@ and R. conori are possible. A new approach to the treatment 
of such patients is outlined. 
I P609 I Clinical Manifestations of Lyme Disease in 
Belams 
N. Trofimov V Scherba L. Titov ' , E. Danilov ', A.I. Korzan *. 
'Byelomssian Research Institute for Epidemiology and M i ~ o b i o l o ~ ,  
Minsk, Republic of Belarus, 'Clinical Hospital of Brest Region, Republic 
of Belarus 
Objectives: To study prehmnary data on characteristics and pecu- 
liarities of Lyme Disease (LD)  course in Byelorussian population. 
Methods: 24 patients with LD were examined by us in 
1995-1996. The disease was diagnosed on the basis of migrating 
erythema (ME) in anamnesis, revealed during a physician's examina- 
tion or h m  the patients complaints. It was verlfied by detecaon of 
antibodies against Borrelia burgdofm' in blood sera with the help of 
indirect immunofluorescence assay 
Results: ME was a most fiequently occurred symptom h m  all 
clinical d e s t a t i o n s  (87%). Cutaneous manifestations were accom- 
panied by common infectious syndrome in 10 cases (47%), that was 
expressed in fever of different rates, as well as in head, muscle and 
joint pains. Disturbances in cardIo-vascular system were reported in 
9 patients (38%), they were attended by unpleasant sensation and 
pains in heart. Various rates of blockade in conducting system and 
atrial extrasystoles were also identified in elecaocardiogrammes. The 
signs of anicteric hepatitis in the form of nausea, feeling of heavi- 
ness, located in right hypochondrium, enlargement of liver size and 
elevation of transaminase levels 2-3 times were established in 3 pa- 
tients (12%). Serous meningitis ofborrelia etiology was diagnosed in 
4 patients (17%). 
Conclusions: ME and common infectious syndrome are main 
clinical signs of LD. Lower prevelance of other symptoms, which 
are typical at late stages, appears to be conditioned by the early 
administration of antibiotics to patients. 
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1 P610 I Prevalence of Bomlia burgdohti Antibodies in 
D. Tuncer',D. Colak', E Saym2,D. O@inc',  C. Ergin', 
B. Tuncer3, G. Mutlu'. 'Akdeniz University CIin. Microbiology Dqt ,  
Antalya, Turk% 'Ankara University Veterinary Faculty, Ankara, Turkey, 
3 ~ t a r e  Hospital Finike, Turkey 
Objectives: An epidemiological study on Lyme disease was made 
by comparing the populations of mountain villages and city centers. 
Methods: 244 subjects h m  mountainous areas and 124 subjects 
finm city centers were examined with respect to Lyme &ease. B. 
burgdofm' IgG antibodies were searched for in the sera of subjects 
by microelisa technique. Positive results were later confirmed by 
Western blot techmque. Ticks  we^ collected h m  goats and sheep, 
which are in close contact with the people in endemic regions, and 
presence of Ixodes species, which are the reservoir of B. burgdorfen' 
was inveswted. 
Results: By microelm, 22.1% of rural and 6.4% of urban popula- 
tions were shown to have B. burgdorferi IgG antibodies. By Western 
blot 80.6% of positive cases confirmed to be positive. 80.4% of ticks 
were idenhfied as Ixodec ricinus 
Conclusion: This study suggests that Lyme disease might be con- 
sidered as endemic in rural areas of Antalya. 
Urban and High Risk Areas 
I P611 I Standardization of Western Blotting in Lvme 
A. Lakos. Lyme Disease Center, Budapest, Hungary 
Objective: New standardization of Western bloning in LB, specifi- 
cation of specific and aspecific bands, using Borreha ahelii (BA) as 
antigen. 
Methods: The proteins of BA (ACA1) were separated by PAGE 
and blotted onto Immobilon membrane. The immune reaction was 
carried,out with 100 serum samples each of the following clinically 
defined groups: erythema migrans - EM (l), Bannwarth-syndrome 
- BS (2), acrodermatitis chi. atrophicans - ACA (3), infants (4), 
healthy blood donors - HBD (5), forestry workers (6) and uveitis 
patients (7). Groups 1-3 represent Merent clinical manifestations of 
Lyme &ease, groups 4-7 served as control. IgM and IgG antibodies 
were tested separately. In group 2, CSF samples were also evaluated. 
Altogether 1600 tests were done. The intensitiy of bands was esti- 
mated and scored finom 0 to 3. Location of bands was defined with 
monoclonal antibodies. Statistical evaluation was done by EPINFO 
and SPSS PC. 
Results: IgM antibodies against both the 22 kD and 41 kD pro- 
tein was found to be 100% spenfic. However, IgM testing has a 
low diagnostic value, because only five EM and nine BS patients 
had IgM but no IgG antibodies. Anti-flagellar (41 kD) and anti-39 
kD IgG antibodies were not spec& at all, in contrast with many 
previous studies. Specfic bands were 22; 29; 35; 44; 47; 49; and 
93 kD. The best specificity/sensitivity ratio was found when cut-off 
level was s e t  up at score 1.5 (one strong plus one faint reaction at 
the above-mentioned bands). According to t h ~ ~  criteria, only three 
HBDs and no dants were positive. The sensitivity of IgG tests 
among consecutive EM and BS patients was 40 and 63%. respec- 
tively. In BS, when both CSF and serum, IgG and IgM were evalu- 
ated, the sensitivity was 88%. After six weeks the first symptoms, all 
BS patients were positive as well Y the ACA patients. 
Conclusion: We found a specificity pattern difierent h m  pre- 
vious studies. Our results suggest that specific Western blot pattern 
may vary strain by s m i n  and there is no universally valid specific 
Western blot bands. This work should be repeated for any borrelia 
isolate candidate for dugnostic purpose. 
Borreliosis (LB) 
(p612( Ti-Borne Borreliosis or Infectious 
Mononucleosis - A Diagnostic Challenge in 
Children 
L. Krbkwi 
Mendel Children's Hospital, Univmity of Bmo, Czech Republic, 
'Hygiene Institute, Bmo, Czech Republic 
Objectives: To examine IgM seropositivity against Bonelia burgdor- 
fm' (Bb) with nonspecific symptoms for tick-borne borreliosis in 
pediatric patients. 
Methods: 217 children were seen h m  1994 to 1996 for IgM 
seropositivity against Bb. Erythema migram, borrelial lymphocy- 
tom,  neuroborreliosis and Lyme arthritis were diagnosed in 165 
children. We analysed 35 children for possibly cross-reacting an- 
tibodies to rheumatoid and antinuclear factor, to viral capsid and 
nuclear antigen for Epstein-Barr infection. Enzyme-linked im- 
munosorbent assays were used to dqnose Bb or EB infection. 
Westernblots or IgM antibody capture tests are not used routinely 
in primary care practice. 
Results: 26 girls and 9 boys, ages 3 to 18 years with cervical lym- 
phadenopathy, fever, fatigue, cephalea or tonsillitis were repeatedly 
examined. The atypical lymphocytes were found in 16/35 (46%) pa- 
tients. 10/35 (29%) children showed elevated transaminases. 20/33 
(61%) children had positive IgM antibody to viral capsid antigen for 
infectious mononucleosis in the I. sample and only 6/35 (17%) had 
it in 11. During the convalescent phase 54%-83% children developed 
IgG antibodies to EB nuclear antigen. Antinuclear and rheumatoid 
factor were negative in all patients. 
Conclusions: Tick-borne borreliosis and EB infection may both 
be associated with lymphadenopathy or other common features 
of illness. Cases with nonspecific symptoms, IgM seropositivity to 
Bb and those with tick bite history lead to erroneous diagno- 
sis of tick-borne borreliosis. IgM seropositivity to Bb in 35/217 
(16%) children with infectious mononucleosis supports the knowl- 
edge about false-positive serology in diseases with polydonal B cell 
activation. 
M. KapZkovi *, I. Stefflovi', J. Kunicki 9. G. 
(p613j Evolution of the Immune Response in Mients 
with Erythema Migrans 
G. Grabher, B. Redl, P. Loidl, G. Sto5er. Instifute o f M i m b i o l o ~ ,  
Uniwrsity oflnnsbruck, Medical Shl, Austria 
Objectives: To assess the evolution of the immune-responses of 
patients with EM during the course of disease using immunoblots 
(IB) with extracts from three Borrelia genotypes and recombinant 
proteins. 
Methods: A total of 259 serially collected sera b m  97 phyucian 
documented patients with known duration of EM were analyzed by 
immunoblotcing for IgM and IgG, using extracts b m  strains B31 (B. 
burgdofm' sensu stricto), PKo (B. afzeliil), PBi (B. garinit), recombinant 
proteins OspA, OspB, OspC, flagellin (and two Merent central 
hgments P41i), P39 and P100/83 horn B. garinii and a commercial 
DotBlot. Evaluation was, if applicable, as recommended by CDC 
and ASTPHLD. 
Results: From 45 patients which presented with EM of less than 
7 days in duration 8 (18%) were IgM positive in IB, whereas h r n  
52 patients with EM of 7-14 days in duration 47 (90%) were IgM 
positive. In total, the serum samples b m  88 (91%) of the patients 
revealed a seroconversion within 2-4 weeks after appearance of EM. 
IgM to OspC and flagellin remained detectable for long periods, up 
to 6 month in some patients. 
Conclusions: The appearance of IgM in Il3 correlated directly 
with duration of EM. The Merences in the reactivities with OspC 
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in dependence of the genospecies used for IB were generally com- 
pensated by detection of antibodies to P39, P41i and/or P100/83. 
I P6141 Urinary Excretion of 6. burgdorfefiDNA in 
Patients with Lyme Borreliosis 
B.L. Schmidt, E Breier, E. Aberer. L B I f  dermato-wenerolog, 
Serodiagnosis, Vienna, Ausfria 
Objectives: To determine the urinary excretion of B. burgdoferi 
(Bb)-DNA in patients with Lyme borreliosis after therapy. 
Methods: Urine samples (n = 442) h m  134 patients (pat.) with 
uncomplicated erythema migrans (EM) or with EM accompanied 
by systemic symptoms, fever, chills, paresthesia, arthralgia or myalgia 
@MA), were tested before and up to one year after therapy by a 
nested PCR for the presence of Bb-specific DNA. 
Results: Immediately after end of therapy, 79% of pat. were pos- 
itive by PCR. After 6 months, all but 9 were non reactive. Reeval- 
uation of these 9 pat. showed interruption of treatment or treatment 
duration of only 5-10 days in 7 pat.. All could be retreated for 
20 days with ceftriaxon and urine controls after three months were 
negative by PCR. 
Conclusion: Sensitive PCR-tests can demonstrate Bb-DNA in 
urine of pat. after matment. A persistent reactivity six months later 
indicates treatment failures. 
I P615 I Systemic Reaction in Patients Treated with 
Cefotaxime for Lyme Disease 
Ch. Jvlichel ', J.-E? Collet2. ' D u g  Surveillance Dept., Hoe& AG, 
Frankfurt, Germany, 'Dept. of Epidemiology and Biostatistirs McGill 
University, Montreal, Canada 
Objectives: Starting in 1989 a couple of adverse reaction reports 
were received fium the US in which the occurrence of a new sys- 
temic reaction - also reported as "delayed Jarisch-Herxheimer Re- 
action" - was idenhfied in patients treated with cefotaxime for Lyme 
disease. This study was undertaken to investigate whether this re- 
ported systemic reaction could be considered as a new adverse drug 
reaction to cefotaxime or the expression to the underlying Lyme 
disease. 
Methods: All spontaneous adverse reactions reports received 
by Hoechst AG h m  the US within the period 01/Jan/87 to 
31/Dec/93 were reviewed. An operational definition of the ob- 
served systemic reaction was established and reports were classified 
in five categories according to the probabihty to represent a case of 
the reaction: certain, possible, unlikely, highly unlikely or excluded. 
Results: A strong association between Lyme &ease as the indica- 
tion for cefotaxime treatment and the systemic reaction was detected 
97% (30/31) of the cases identified as certain were treated for Lyme 
disease, as opposed to 90% (27/30), 69% (31/45), 39% (651167) and 
11% (42/392) of those idenhfied, respectively, as possible, unlikely, 
highly unlikely and excluded. 
Conclusions: This suggests that the new reported systemic ad- 
verse event may not be due to cefotaxime on its own but that it 
may either represent a combined effect of the drug and disease or 
persistent symptoms of the underlying Lyme disease not resolved by 
antibiotic theram. The possibility of an effect of long treatment du- 
ration of cefotaxime cannot be completely ruled out, but remains 
very unlikely. 
I P616 I Detection of 60rrelia burgdohriDNA in Muscle 
of Patients with Chronic Myalgias Related to 
Lyme Disease 
M. Frey I.', J. Sibha 3 ,  Y. PiCmont ', L. Marcellin ', E? Boohs ' , 
E? Vautravers ', M. Jesel', J.L. Kuntz ', H. Montes', B. Jaulhac '. 
'Services de Mbdecine Physique et Rhadaptation, Strarboutg, France, 
'd'Explorations Fom'onnelles Neuromusculaires, Strarbourg, France, 'de 
Rhumatologie, Strasbourg, France, 4d'Anatomo-Pathologie Ghnhafe, 
Strarboutg, France, 'Institut de Bactk.iologie, Strarbourg, France 
Objectives: Chronic myalgias related to Lyme disease are generally 
considered as sequelae. Our objectives were to establish whether 
Bonelia burgdorferi (E?. burgdoferi) may persist in the muscle of patients 
in such a case and to evaluate the contribution of a PCR assay for 
detecting this bacteria. 
Methods: In a prospective case-control study, B .  burgdoferi DNA 
detection was performed by PCR on muscle biopsies of 8 con- 
secutive patients with chronic widespread myalgias related to Lyme 
disease. The PCR assay used a specific chromosomal fragment of 
the flagellin gene. Other classical causes of myalgias were ruled out. 
Muscle samples from 14 controls were also tested. 
Results: B .  burgdo& DNA was detected by PCR in muscle 
fium 4 of the 8 patients but not in controls. Three of the 4 positive 
patients had previously received an antibiotic treatment for Lyme 
disease; PCR analysis was done 3 months after antibiotic treatment 
for 2 of these 3 patients and 38 months for the thud one. 
Conclusion: Chronic myalgm related to Lyme disease can be 
associated with persistence of B. burgdofm' DNA in muscle, even 
despite previous supposedly curative antibiotic treatment. 
m] Risk of Lyme Bomliosis after a Tick Bite in the 
I. Nahimana ' , 0. Peter *, L. Gern ', G. Praz ', F? Francioli ' . 
'CHVY Lausanne, Switzerland, 'Insf. Central des Hbpitaur bblaisans, 
Sion, Switzerland, Unioersid de NeucMtel, Switzerland 
Objectives: To evaluate the risk of acquiring Lyme borreliosis after 
a tick bite and to correlate the risk with the presence of Borrelia sp 
in the ticks. 
Method Since 1993, physicians of the French part of Switzer- 
land were asked to report on all patients consulting for a tick bite. 
The protocol included a standardized questionnaire, two blood sam- 
ples collected two months apart and mailing of the tick if available. 
Serology was performed with both a commercial test (Lyme IgG + 
M, Vidas Biomerieux) and a westernblot assay detecting both IgG 
and IgM. Criteria for positive immunoblot were a minimum of 5 
bands including flagelhe and 2 of the following specific bands: P39, 
OspA, OspC 93 kDa. Seroconvenion was defined by passing h m  a 
negative immunoblot result to a positive one at the second sampling. 
Ticks were analyzed either by immunofluorescence or PCR with 
species-specific primers. 
Results: Among 510 patients who had a negative serology at the 
first visit, 40 (8%) seroconverted. The rate of seroconversion was 
4% in the 297 patients who consulted because of the tick bite only 
(group I), 7.5% in the 121 patients with a s m a l l  local reaction at the 
site ofthe bite (group 2) and 21% in the 92 patients who already had 
a lesion qu-g (25 cm) for an erythema migrans (EM): (group 
3). Among the 418 patients of group 1 and 2, 8 (2%) developed an 
EM, among which 4 seroconverted. Among 179 analyzed ticks, 26 
were positive. No correlation could be found between Bonelia sp in 
ticks, and clinical and/or serological results. 
Conclusions: In patients consulting for a tick bite without EM 
(group 1 and 2), the rates of seroconversion and EM were 5% and 
2%, respectively. Seroconvenion and subsequent EM was more ke- 
French Part of Switzerland 
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quent in patients with small local lesions (group 2). suggesting that 
these lesions often represent Bonefia sp infection at an early stage. 
[P618 I Association of Distinct Clinical Manifestations in 
Chronic Lyme Bomliosis with Bonelia 
burgdorhri sensu stricto, B. garinii and B. afzelii 
as Evaluated by lmmunoblot 
0. Peter, A.G. Brea, E. Dayer. Institut Central des HGpitaux 
Ihlaisans, Sion, Switzerland 
Objective: To evaluate the serologic reactivity ofpatients with Lyme 
arthritis, neuroborreliosis and Acrodermatitis chronica atrophicans 
(ACA) by immunoblots using B. burgdofm' sensu strict0 (s), B.  garinii 
and B. afrelii as antigens. 
Methods These 3 borrelia species are transmitted by Ixodes ricinus 
in Europe. A total of 81 patients with chronic symptoms of Lyme 
borreliosis (28 patients with arthritis, 28 with neuroborreliosis, 25 
with ACA) were analysed by immunoblots using B. burgdofen ss, B .  
garinii and B. afzelii as antigens. In order to give a semi-quantitative 
appreciation of the reactivity, we scored (0 to 3 points) the intensity 
of the reaction to seven borrelia antigens ranging from 18 kDa to 93 
kDa. 
Results: The serologic reactivity of patients with chronic man- 
ifestations of Lyme borreliosis was as follow: 62% of patients with 
neuroborreliosis reacted more intensively with B. garinii, 71% of 
patients with arthritis reacted with B .  burgdogm' ss and 80% of pa- 
tients with ACA reacted with B. afzelii. Usually criteria for positive 
immunoblot were reached whatever the Borreha species was. The 
stronger reactivity for one species was visually obvious and scores 
helped to objectivate the readings. 
Conclusions: These associations between the symptoms and the 
preferential serologic reactions to Werent Borrelia species may give 
additional arguments for the diagnosis of chronic Lyme borreliosis. 
I P619 I Characterization of a Low Molecular Weight 
Lipoprotein Specific of B. garinii, Recognized by 
the D6-Mab 
E. Dayer, A.G. Brea, 0. Peter. Imtitut Central des HGpitaux 
Valaisans, Sion, Switzerland 
Objective: To characterize the epitope recognized by D6-Mab spe- 
cific of B. garinii. 
Introduction and Methods: Specific symptoms of chronic Bor- 
rekosis have been related to persistent infection with Herent Borre- 
lia species. In Europe, neuroborreliosis has often been associated with 
B .  garinii infections, while other symptoms, acrodermatitis chron- 
ica amphians (ACA) and arthritis, have been associated with B.  
afrelii and B. burgdofm', respectively. Typing the Werent isolates by 
their reactivity to spec& monoclonal antibodies is possible by im- 
munoblotting. We used standard SDS-PAGE 1D and 2D gels with 
PVDF membrane transfer, as well as N-terminal sequencing to char- 
acterize protein. 
Results: D6-Mab recognized specifically B. garinii; the specific 
antigen is a surface lipoprotein of 11.2 kD and an estimated pkl of 
5.7. Its N-terminal portion sequenced h m  PVDF transfer mem- 
brane gave the following sequence: MVKKEAIIKAVNGLLVXP: 
The search for homologies revealed no identity and homologies of 
only 40% with POL-SOW3 non structural protein and with other 
ribosomal and peripksmic proteins. Using polyclonal antisera from 
chronically infected patients, we were able to show a major reactive 
protein in the same kD range in other Borrelia species, although it 
migrates in slightly Nerent position according to species. 
Conclusion: The protein recognized by D6-Mab is Uely an 
outer surface protein (OSP) so far undescribed and we are in the 
process of characterizing it, knowing its imporrance for species typ- 
ing and dagnosis. 
1 P620 1 Development and Evaluation of Confirmatory 
Tests for Lyme Disease Using an Extract of B. 
garinii 
K. Gimrdet ', L. Binet', 0. Peter'. 'Imtifut Central des Hdpitaux 
Vafaisans, Sion, Switzerland, 'Lubodia S.A., Em, Switzerland 
Lyme hsease serology remains extcemely complex and positive re- 
sdts  by ELISA require confirmatory tests (immunoblot or PCR). 
Most commercial confirmatory tests currently available are h m  US 
origin and use as target antigens emc t s  from Borrelia burgdorferi. 
In Western Europe, s t r a i n  prevalence is Herent and we have devel- 
oped two immunoblots (IgG and IgM) with an extract of B .  garinii. 
These kin allow the identification of antibodies against proteins of 
93, 60, 41, 39, 37,32.5,22-23 and 18 kD. 
C h c a l  tr& organized in Switzerland have shown large geo- 
graphcal variations in the seropositivity rate of the overall popu- 
lation. The speciticity of the luts has been evaluated for possible 
cross-reactions with syphilis or EBV antibodies and with autoan- 
tibodies. The sensitivity of the IgG immunoblot reaches 100% for 
Lyme arthritis, 96% for acrodermatitis, 90% for erythema migrans 
and 89% for neuroborreliosis. 
Toxoplasma gondii 
I P621 I Prevalence of Toxoplasma Gondii Antibodies in 
Young Females of La Plata, Argentina 
J. Cordhi ,  M. Rub, G. Alberich, J. Contarelli, L. Massera, 
M. Michaan, M. Garcia, S. Cabrera. Infecous Diseases Department, 
Hospital San Juan de Dios, La Plata, Argentina 
Objective: To determine the seroprevalence of Toxoplasma gondii 
(TG) antibodies in urban and suburban young females f inom La Plata, 
Argentina. 
Subjects and Methods: Samples from 271 consecutive healthy 
females were collected between February to October 1995. Serum 
was tested with indirect Hemaglutination with and without 2-mer- 
captoethanol. Positive test were confirmed with enzyme linked im- 
munoassay. 
Results: The meda age was 22 (range 15-45). 156 (57.56%) liv- 
ing in the city, and 115 (42.43%) in a rural area close to La Plata. 
No Werences were found for social, cultural, religious or econom- 
ical conditions between the groups. Dietary habits and frequency of 
contact with atmnals (including pets) were Werent (p 0.005). 
A global seroprevalence of 43.5% (118/271) was found. Values 
were higher in the rural group: 53.5% than in the urban (36.8%) 
p > 0.009. Moreover, the prevalence increase with the age, with 
significative aerence  up to 33 yrs. (p = 0.008). 
Commentary: Suburban residence enhance the possibility to get 
TG as simJar as dietary habits and close contact with animals. The 
seroprevalence raise with the age. Because 56.5% of females were 
noreactives at wedding time, screening programs are necessary for 
pre-nuptial detection. 
